Skip to main content
Year archive

VITASORA HEALTH LIMITED — 2017 filings

All 36 regulatory filings released by VITASORA HEALTH LIMITED (VHL) in 2017, sourced directly from the official regulator.

36 Filings
2017 Period
2017 filings (36)
Filing Released Lang
Appointment of Director & Board Remuneration 2 pages 451.5KB
Board/Management Information
2017-12-21 English
Appendix 3Z - Final Director's Interest Notice 2 pages 83.6KB
Director's Dealing
2017-12-20 English
Appendix 3X - Initial Director's Interest Notice 2 pages 78.4KB
Director's Dealing
2017-12-20 English
Appendix 3Y - Change of Director's Interest Notices (x2) 4 pages 91.0KB
Director's Dealing
2017-12-20 English
Appendix 3X - Initial Director's Interest Notice 3 pages 577.9KB
Director's Dealing
2017-12-20 English
Appendix 3B 14 pages 129.4KB
Capital/Financing Update
2017-12-19 English
Results of 2017 Annual General Meeting 1 page 104.9
Declaration of Voting Results & Voting Rights Announcements
2017-12-14 English
2017 AGM - Chairman's Address 18 pages 1.0MB
Investor Presentation
2017-12-13 English
AGM - Change of Venue & Start Time 2 pages 451.3KB
AGM Information
2017-11-28 English
2017 Notice of Annual General Meeting and Proxy Form 30 pages 1.1MB
AGM Information
2017-11-13 English
Appendix 4C - quarterly 5 pages 193.8KB
Interim / Quarterly Report Q1 2018
2017-10-29 English
AirSonea Generation 2 Breath Sensor Update 2 pages 466.0KB
Regulatory Filings
2017-10-29 English
Extension of Date for Annual General Meeting 2 pages 450.8KB
AGM Information
2017-10-25 English
Respiri Receives Notice of Intention 1 page 437.5KB
Board/Management Information
2017-10-16 English
Respiri Appoints New Chief Executive Officer 3 pages 480.6KB
Board/Management Information
2017-10-15 English
Response to ASX Price Query 5 pages 429.0KB
Regulatory Filings
2017-10-10 English
Breath Sensor Partnership with Grey Innovation Commenced 2 pages 442.1KB
Regulatory Filings
2017-09-11 English
Appendix 4E & Annual Financial Report (30 June 2017) 64 pages 2.5MB
Annual Report FY 2017
2017-08-29 English
Change of Registered Office 2 pages 450.0KB
Regulatory Filings
2017-08-10 English
Respiri remains on track for commercialisation 2 pages 446.7KB
Regulatory Filings
2017-08-08 English
Appendix 4C - quarterly 5 pages 195.6KB
Interim / Quarterly Report Q4 2017
2017-07-26 English
Commencing the last step to commercialisation 3 pages 475.1KB
Capital/Financing Update
2017-07-26 English
Respiri & China 2 pages 685.4KB
Regulatory Filings
2017-05-29 English
Executive Chair Remuneration Update 2 pages 451.7KB
Remuneration Information
2017-05-16 English
Company Secretary Appointment/Resignation 2 pages 449.0KB
Board/Management Information
2017-05-16 English
Partner Discussions Encouraging 1 page 581.9KB
Capital/Financing Update
2017-04-26 English
Appendix 4C - Quarterly 5 pages 194.2KB
Interim / Quarterly Report Q3 2017
2017-04-26 English
European CE Mark Approval Received 3 pages 168.6KB
Regulatory Filings
2017-04-11 English
Appendix 3B 13 pages 528.9KB
Capital/Financing Update
2017-02-28 English
Appendix 3B 14 pages 944.8KB
Share Issue/Capital Change
2017-02-27 English
Text and App Messaging for Better Asthma Care 1 pag
Regulatory Filings
2017-02-27 English
Respiri Appendix 4D and Interim Financial Report - Dec 2016 18 pages 1.4MB
Interim / Quarterly Report H1 2017
2017-02-26 English
Appendix 3B 13 pages 529.6KB
Capital/Financing Update
2017-02-26 English
Corporate Advisor for Partner Transactions 1 page 4
Capital/Financing Update
2017-02-08 English
RESPIRI COMPLETES CORE SOFTWARE PLATFORM 2 pages 570.1KB
Regulatory Filings
2017-01-30 English
Dec 16 Appendix 4C - Respiri 5 pages 193.3KB
Interim / Quarterly Report Q2 2016
2017-01-30 English